← Pulse/Companies

Colossal Biosciences on Pulse

Biotech

The full thread of our Colossal Biosciences coverage — a running record of every development we've tracked, with the VC take on each.

2
Stories
2
With a headline figure
Jul 20, 2026
Date

Coverage Timeline

newest first
  1. FUNDINGColossal Biosciences in Talks to Raise at Up to $30B Valuation→
  2. FUNDINGColossal Biosciences in Talks to Raise at $20B-$30B Valuation→

All Coverage

FUNDING$20B-$30B talks

Colossal Biosciences in Talks to Raise at Up to $30B Valuation

Colossal Biosciences is reportedly in talks to raise new capital at a $20-30 billion valuation, up to triple its January 2025 mark, building revenue-generating spinouts beyond its mammoth and dire wolf projects.

Jul 20, 2026
FUNDING$20B-$30B valuation

Colossal Biosciences in Talks to Raise at $20B-$30B Valuation

De-extinction genetics company Colossal Biosciences is reportedly in talks to raise new capital at a $20 billion to $30 billion valuation, a dramatic step up that would make it one of the most valuable biotech startups in the world.

Jul 20, 2026